Despite the widespread use and standardization of ALT for liver disease screening, such as in Non-Alcoholic Fatty Liver Disease (NAFLD), there is no consensus on the upper limits of normal ALT levels in children. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.